- Open Access
CSF/serum quotient graphs for the evaluation of intrathecal C4synthesis
© Padilla-Docal et al; licensee BioMed Central Ltd. 2009
- Received: 03 February 2009
- Accepted: 02 July 2009
- Published: 02 July 2009
Cerebrospinal fluid (CSF)/serum quotient graphs have been used previously to determine local synthesis in brain of immunoglobulins and C3 complement component. The aim of this study was to use the same technique to construct quotient graphs, or Reibergrams, for the beta globulin C4 and to evaluate the method for assessing intrathecal synthesis in neurological disease.
The constants in the previously-defined Reibergram for immunoglobulin IgA were used to calculate the CSF/serum quotient for C4. CSF and serum were analyzed for C4, IgA and albumin from a total of 12 patients with meningoencephalitis caused by encapsulated microorganisms and 10 subjects without infections or inflammatory neurological disease, some of which had dysfunction of the blood-CSF barrier,
The formula and C4 Reibergram with the constants previously found for IgA, determined the intrathecal C4 synthesis in CSF. The intrathecal C4 fraction in CSF (C4 loc in mg/l) was compared to the C4-Index (fraction of CSF: serum for C 4/fraction of CSF: serum for albumin). There was a significant correlation between the two formulae. The CSF/Serum quotient graph was superior for detecting intrathecal synthesis of C4 under variable conditions of blood-CSF barrier permeability.
The C4 Reibergram can be used to quantify the intrathecal synthesis of this component of the complement system in different infectious diseases of the central nervous system and is especially useful for patients with blood-brain barrier dysfunction.
- Progressive Supranuclear Palsy
- Quotient Graph
- Hyperbolic Line
Cerebrospinal fluid (CSF) analysis has great potential for the diagnosis of neurological diseases. Reibergrams or CSF/serum quotient graphs [1, 2] are diagrams that analyze in an integrated way both the function of the blood-CSF barrier and intrathecal protein synthesis, to aid in the diagnosis of central nervous system (CNS) diseases associated with specific patterns of immunoglobulin response. This diagram was first defined for the major classes of immunoglobulins [2, 3] empirically based on the results of thousands of profiles and was subsequently confirmed by application of Fick's law of diffusion in the theory of molecular diffusion/flow rate . Fick's law states that the diffusion of a protein through a barrier depends on the diffusion coefficient of the molecule and on the concentration gradient between the compartments on either side of the barrier. The diffusion coefficient depends on the molecular size of the protein. Fick's second law shows how the local concentration gradient is nonlinearly modified by variations in the CSF flow rate. The theory of molecular diffusion/flow rate of CSF explains that the diffusion of proteins through the blood/CSF barrier has a hyperbolic distribution and is able to explain the physiological and pathophysiological dynamics of proteins in the CNS. This has permitted its use for other immunoglobulins such as IgG3 , IgE  and more recently C3c .
The complement system is one of the humoral mediators of immunity and inflammation; it is formed by more than thirty plasma and membrane proteins. Raised levels of C4, one of the components, may be found in the CSF in lupus meningoencephalitis [8, 9], in progressive supranuclear palsy  and other neurological diseases  such as autism , schizophrenia , cerebral parenchymal cysticercosis , meningoencephalitis  and brain tumors . Cytokines associated with amyloid plaques in Alzheimer's disease stimulate human glial and neuronal cell cultures to secrete early complement proteins [17, 18]. Some of these proteins are bound to immunoglobulins or to components of the cellular membrane , although they normally circulate in the form of pro-enzymes with a latent pro-enzyme activity.
C4 protein is a beta globulin with a sedimentation coefficient of 18.7, molecular weight 200 kDa and a serum concentration of 430 μg/mL. It is activated by the complement system and is a C2 receptor. C4a acts as anaphylatoxin similar to C3abut is weaker, while C4b acts as an opsonin promoting phagocytosis by binding to complement receptors. It is important to assess C4 intrathecal synthesis if the classical complement pathway has been activated in infectious and autoimmune neurological diseases. Combined with analysis of C3c intrathecal synthesis [20, 21], this knowledge is needed to understand the pathophysiology of these disorders.
The aim of this paper was to construct quotient graphs (Reibergrams) for the beta globulin C4 and to determine the intrathecal synthesis of C4 in patients with bacterial meningoencephalitis. To do this we used IgA which has molecular characteristic similar to the C4 molecule and its previously-defined CSF/serum quotient graph, to create the formula and Reibergram for C4.
Twelve patients with meningoencephalitis caused by encapsulated microorganisms were studied: nine patients suffering from Streptococcus pneumoniae and three with Haemophilus influenzae (mean age of 32.5 years, range 3 to 46 years). A control group consisted of ten subjects without infections or inflammatory neurological disease and that did or did not have dysfunction of the blood-CSF barrier (mean age 17 years, range 9 months to 48 years), The research was approved by the Committee on Bioethics Research of the Faculty of Medical Sciences, Dr. Miguel Enriquez Superior Institute of Medical Sciences of Havana, Havana City, Cuba. All patients and persons whose samples were used as controls, and parents or tutors of the children gave their informed consent to carry out a diagnostic lumbar puncture.
CSF and serum samples
CSF samples were obtained by lumbar puncture and simultaneous blood samples were taken to obtain serum. Cells were removed from CSF by centrifugation and samples with blood contamination were eliminated. Control samples were from CSF and serum collections held in our laboratory from patients with suspicion of meningoencephalitis but were subsequently found to have febrile convulsions without biological agents or verified autoimmune causes. Aliquots of both patient and control samples were kept at -70°C for up to 30 days after the puncture date before analysis.
Analysis of CSF and serum
C4, IgA and albumin were quantified by radial immunodiffusion with NOR PARTIGEN© and LC PARTIGEN© plates (Dade Behring, Marburg, Germany) for serum and CSF, respectively. Radial immunodiffusion detects the reaction of antigen and antibody by a precipitation reaction based on the principle that a quantitative relationship exists between the amount of antigen placed in a well cut in the agar-antibody plate and the resulting ring of precipitation. This end point method requires that the precipitation rings reach the maximal possible size, which often requires 48–72 h of diffusion. A standard curve was experimentally determined with known standards and used for the determination of protein concentration corresponding to any diameter size.
C4Reibergram and index
As a cut off for discrimination between a normal and pathological C4-Index, we used C4-Index = 0.46
Molecular characteristics of immunoglobulins and complement proteins
Molecular Mass (kDa)
Hydrodynamic radius (nm)
Where Q C4 (lim) is the upper discrimination line of the reference range, Q C4 = C4 (CSF)/C4 (Serum), a = intercept hyperbole value on the y axis, b = x value to asymptotic hyperbole line, c = constant and a/b = hyperbole slope. The following values previously obtained for IgA were used: a/b = 0.77, b2 = 23 × 10-6, c = 3.1 × 10-3.
The program MEDCALC version 6.0 was used to perform the statistical comparison.
Mean value, range and coefficient of variation (CV) in CSF and serum for C4and IgA
CSF C4 (mg/L)
Serum C4 (g/L)
Q C4 × 103
Q Alb × 103
CSF IgA (mg/L)
Serum IgA (g/L)
QIgA × 103
Comparison of the results for intrathecal fraction of C4 in CSF calculated as C4 loc (mg/l) and as the C4-Index in patients with inflammatory disease and non-inflammatory controls.
Intrathecal C4 fraction
C4 loc > 0
C4 loc < 0
Non inflammatory controls
There was a positive correlation between the C4-Index and the CSF/Serum quotient graph for C4, r = 0.7287 and range 0.4432 – 0.8800, for a confidence interval of 95%, p = 0.0001. The general sensitivity of C4-Index, i.e. the probability that this result will be positive when the inflammatory process is present, was only 66% of true positive rate. The C4-Index general specificity was 85%, meaning that the probability that the C4-Index will be negative when the inflammatory process is not present was 85% of true negative. The positive predictive value or the probability that the inflammatory process is present when the index is positive was 75% and the negative predictive value or the probability that the inflammatory process is not present when the index is negative was 80%. Hence the C4 quotient method (Reibergram) was found to be superior in sensitivity, specificity and predictive values.
The complement system consists of more than thirty proteins and has three types of activation pathways: classical, lectin and alternative pathways. The complement system not only has a role in innate immunity but also works as an antibody-dependent effector to eliminate pathogens. In serum, normal or decreased levels of C3 and C4 are associated with specific immune-mediated diseases. In patients with immune-mediated diseases in the CNS, it is essential to measure complement activation in CSF and the intrathecal synthesis of complement proteins.
The immune response within the CNS has specific characteristics associated with a reduced immunological environment, being a unique and special compartment without much peripheral regulation. The CNS humoral immune response is different from the immune response observed in blood, mainly because there is no switch from the IgM class response to IgG or IgA class response in the CSF in the course of inflammatory neurological disease. The pattern of intrathecal IgG/IgA/IgM synthesis remains fairly constant and depends on the cause, pathophysiology and localization of the disease process [3, 4]. In addition, it is known that there is a long-lasting but slow decay of intrathecal antibody synthesis, sometimes detectable up to 20 years after sufficient treatment (e.g. in neurosyphilis, neuroborreliosis or HSV-encephalitis). In CSF, there are polyclonal and polyspecific immune responses in diseases like multiple sclerosis [20, 24]. Recent studies have demonstrated that the intrathecal synthesis of C3c is associated with infectious  and autoimmune disease .
Studies carried out on the passage of different blood proteins into the CSF have established different models that tried to explain their differential diffusion into the cerebral compartment. The theory of protein flux/CSF flow [4, 24] suggests that there is no loss of selectivity during dysfunction of the blood-CSF barrier, and that the only variable determining the speed of passage of a blood protein into CSF is the coefficient of molecular diffusion which is inversely proportional to the molecular size of the protein. The protein concentrations in CSF depend on blood concentration, blood-CSF barrier function and intrathecal synthesis . In order to know if a protein in CSF is brain-derived it should have at least one of the following characteristics: a higher CSF concentration than in serum, the blood-derived fraction in CSF significantly lower than brain-derived fraction, or if the coefficient of variation (CV) of the serum concentrations is larger than CV in CSF. In our experiment, the C4 concentration in blood was larger than in CSF in controls and in patients with meningoencephalitis. In the patient group, the CV in CSF was larger than in serum but in the control group, the CV was not larger in CSF than in blood. This suggests that although C4 is a blood-derived protein, during the inflammation process there was an increased amount produced in brain. This study showed that 75% of patients with meningoencephalitis had intrathecal C4 synthesis with or without dysfunction of the blood-CSF barrier as indicated by its QAlb value which varies according to age. In addition, the control group with variable QAlb values was in the normal range, indicating no intrathecal synthesis, which is consistent with the absence of cerebral inflammation in this group . Also noteworthy is that none of the evaluated cases was placed below the lower hyperbolic curve, which is an area with no biological explanation. In medical practice, a technical error in protein quantification is suspected when a case falls in this area, so this is a quality control for the method.
Using the previously-used C4-Index to study intrathecal C4synthesis has disadvantages over the quotient method. The index is a linear formula whereas the distribution of proteins from blood to cerebral compartments follows a hyperbolic curve , thus the C4-Index may produce false results . In addition, indexes can not be applied when there is a dysfunction of the blood-CSF barrier, which greatly limits its application in inflammatory diseases that usually involve barrier dysfunction. There is also a practical problem; the values of the index vary with the volume of extracted CSF since there is a rostro-caudal concentration gradient of proteins passing into CSF, and the first and the following volumes collected have different concentrations . However, it has been demonstrated that since the Reibergram works with protein quotients normalized to quotient (CSF/serum) these are not affected by the extracted CSF volume [1, 25, 27].
Despite these limitations, the results of the C4 Reibergram were compared to those of the index since there is no other known gold standard. There was a positive significant statistical correlation between both methods. Nevertheless, these results demonstrated the superior diagnostic value of Reibergram.
Under all conditions of the blood-CSF barrier, the CSF/Serum quotient graph can identify the occurrence of intrathecal C4 synthesis. It can quantify the C4 fraction which is locally produced in the CNS and differentiate from C4 that may have entered the CSF from blood. On the other hand, the C4-Index should not be used in patients with low QAlb and in particular with high QAlb, i.e. with blood-CSF barrier dysfunction.
The authors would like to thank Manuel Rodriguez for technical assistance.
- Reiber H: Flow rate of cerebrospinal fluid (CSF): a concept common to normal blood CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994, 122: 189-203. 10.1016/0022-510X(94)90298-4.View ArticlePubMedGoogle Scholar
- Reiber H: The hyperbolic function: a mathematical solution of the protein flux/CSF flow model for blood CSF barrier function. J Neurol Sci. 1994, 126: 243-245. 10.1016/0022-510X(94)90283-6.View ArticleGoogle Scholar
- Dorta Contreras AJ: Reibergrama: elemento esencial en el análisis inmunológico de líquido cefalorraquídeo. Rev Neurol. 1999, 28: 996-998.PubMedGoogle Scholar
- Dorta Contreras AJ, Reiber H: Teoría de la difusión molecular/flujo del líquido cefalorraquídeo. Rev Neurol. 2004, 39: 564-69.PubMedGoogle Scholar
- Dorta Contreras AJ: Nuevo Reibergrama para la evaluación de la síntesis intratecal de IgG3. Rev Neurol. 2001, 33: 694-696.PubMedGoogle Scholar
- Dorta Contreras AJ: Reibergrama para la evaluación de la síntesis intratecal de IgE. Rev Neurol. 2004, 39: 794-795.PubMedGoogle Scholar
- Dorta Contreras AJ, Noris Garcia E, Padilla Docal B, Rodriguez Rey A, Bu-Coifiu-Fanego R, Magraner Tarrau ME, Marti Brenes M: Reibergrama para la evaluación de la síntesis intratecal de C3c. Arq Neuropsiquiatr. 2006, 64: 585-588.View ArticlePubMedGoogle Scholar
- Hazouard E, Legras A, Diot E, Ferrandière M, Corcia P, Giniès G: Liquide céphalo-rachidien complément et d'anticorps antinucléaires dans le lupus méningo-encéphalite. Rev Neurol (Paris). 1998, 154: 549-550.Google Scholar
- Jongen PJ, Boerbooms AM, Lamers KJ, Raes BC, Vierwinden G: Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement. Neurology. 1990, 40: 1593-1596.View ArticlePubMedGoogle Scholar
- Yamada T, Moroo I, Koguchi Y, Asahina M, Hirayama K: Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy. Acta Neurol Scand. 1994, 89: 42-46.View ArticlePubMedGoogle Scholar
- Trbojeviæ-Cepe M, Brinar V, Pauro M, Vogrinc Z, Stambuk N: Cerebrospinal fluid complement activation in neurological diseases. J Neurol Sci. 1998, 154: 173-181. 10.1016/S0022-510X(97)00225-6.View ArticleGoogle Scholar
- Ashwood P, Wills S, Water Van de J: The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006, 80: 1-15. 10.1189/jlb.1205707.View ArticlePubMedGoogle Scholar
- Mayilyan KR, Weinberger DR, Sim RB: The complement system in schizophrenia. Drug News Perspect. 2008, 21: 200-210.PubMed CentralView ArticlePubMedGoogle Scholar
- Estanol B, Juarez H, Irigoyen M, del C, Gonzalez Barranco D, Corona T: Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel. J Neurol Neurosurg Psychiatry. 1989, 52: 254-257. 10.1136/jnnp.52.2.254.PubMed CentralView ArticlePubMedGoogle Scholar
- Brandtzaeg P, Høgasen K, Kierulf P, Mollnes TE: The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis. 1996, 173: 647-655.View ArticlePubMedGoogle Scholar
- Fishelson Z, Donin N, Zell S, Schultz S, Kirschfink M: Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. Mol Immunol. 2003, 40: 109-123. 10.1016/S0161-5890(03)00112-3.View ArticlePubMedGoogle Scholar
- Veerhuis R, Janssen I, De Groot CJ, Van Muiswinkel FL, Hack CE, Eikelenboom P: Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol. 1999, 160: 289-299. 10.1006/exnr.1999.7199.View ArticlePubMedGoogle Scholar
- Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, Agostoni A: Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin Exp Immunol. 1999, 115: 526-533. 10.1046/j.1365-2249.1999.00835.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Carroll M: The complement system in regulation of adaptive immunity. Nat Immunol. 2004, 5: 981-986. 10.1038/ni1113.View ArticlePubMedGoogle Scholar
- Padilla-Docal B, Dorta-Contreras AJ, Bu-Coifiu-Fanego R: Activación y biosíntesis intratecal de C3c en niños con meningoencefalitis eosinofílica por Angiostrongylus cantonensis . Rev Neurol. 2009, 48: 632-5.PubMedGoogle Scholar
- Padilla-Docal B, Dorta-Contreras AJ, Fundora Hernández H, Noris-García E, Bu Coifiu-Fanego R, González-Hernández M, Rodríguez-Rey A: C3c intrathecal síntesis evaluation in patients with multiple sclerosis. Arq Neuropsiquiatr. 2007, 65: 800-802.View ArticlePubMedGoogle Scholar
- Fryden A, Forsberg P, Link H: Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis. Acta neurol Scand. 1983, 68: 157-163. 10.1111/j.1600-0404.1983.tb05342.x.View ArticlePubMedGoogle Scholar
- Dujardin BC, Roijers AF, Dreidijk PC, Out TA: The determination of the complement component C1q, C4, and C3 in serum and cerebrospinal fluid by radioimmunoassay. J Immunol Methods. 1985, 80 (2): 227-237. 10.1016/0022-1759(85)90024-9.View ArticlePubMedGoogle Scholar
- Reiber H: Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 2003, 21: 79-96.PubMedGoogle Scholar
- Reiber H, Peter JB: Cerebrospinal fluid analysis – disease-related data patterns and evaluation programs. J Neurol Sci. 2001, 184: 101-122. 10.1016/S0022-510X(00)00501-3.View ArticlePubMedGoogle Scholar
- Reiber H, Albaum W: Statistical evaluation of intrathecal protein synthesis in CSF/serum quotient diagrams. Acta Neuropsychiatrica. 2008, 20: 48-49. 10.1111/j.1601-5215.2007.00266.x.View ArticleGoogle Scholar
- Wurster U: Protein gradient in the cerebrospinal fluid and the calculation of intracerebral IgG synthesis. J Neuroimmunol. 1988, 20: 233-235. 10.1016/0165-5728(88)90165-8.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.